APH — Alliance Pharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Alliance Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	18.4	25	8.03	7.32	0.936
Depreciation
Amortisation
Non-Cash Items	13.2	14.5	22	26	36.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-11	-5.46	2.61	-10.9	-17.6
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities	22.2	35.8	41.6	38.7	21
Capital Expenditures	-2.93	-4.16	-4.61	-5.53	-0.607
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-56.1	0.873	-81.3	0.933	-16.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-59.1	-3.28	-85.9	-4.6	-17
Financing Cash Flow Items	-3.56	-3.91	-3.23	-2.96	-4.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	36.6	-25.2	55.7	-34.3	-0.876
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-0.291	6.94	11.1	0.163	2.65